scholarly article | Q13442814 |
P6179 | Dimensions Publication ID | 1002488801 |
P356 | DOI | 10.1186/1756-6606-6-42 |
P932 | PMC publication ID | 3851374 |
P698 | PubMed publication ID | 24093505 |
P5875 | ResearchGate publication ID | 257460001 |
P50 | author | María Rodríguez-Muñoz | Q42872732 |
Javier Garzón | Q44348750 | ||
Pilar Sanchez Blazquez | Q67590819 | ||
P2093 | author name string | Ana Vicente-Sánchez | |
P2860 | cites work | Paradigm shift in neuroprotection by NMDA receptor blockade: Memantine and beyond | Q22251042 |
The histidine triad protein Hint1 triggers apoptosis independent of its enzymatic activity | Q24296818 | ||
Cannabinoid receptor localization in brain | Q24558751 | ||
Three-dimensional structure of human protein kinase C interacting protein 1, a member of the HIT family of proteins | Q24605226 | ||
Reduced expression of glutamate receptors and phosphorylation of CREB are responsible for in vivo Delta9-THC exposure-impaired hippocampal synaptic plasticity | Q24642505 | ||
Hint, Fhit, and GalT: function, structure, evolution, and mechanism of three branches of the histidine triad superfamily of nucleotide hydrolases and transferases | Q24649493 | ||
The glutamate receptor ion channels | Q28137916 | ||
CB1 cannabinoid receptors and on-demand defense against excitotoxicity | Q28207143 | ||
Cannabinoids inhibit N- and P/Q-type calcium channels in cultured rat hippocampal neurons | Q28245016 | ||
Behavioral despair in mice: a primary screening test for antidepressants | Q28258027 | ||
Calmodulin mediates calcium-dependent inactivation of N-methyl-D-aspartate receptors | Q28281484 | ||
Interactions of calmodulin and alpha-actinin with the NR1 subunit modulate Ca2+-dependent inactivation of NMDA receptors | Q28296865 | ||
Histidine triad nucleotide-binding protein 1 (HINT1) regulates Ca(2+) signaling in mouse fibroblasts and neuronal cells via store-operated Ca(2+) entry pathway | Q28506405 | ||
Evidence for the coupling of Gq protein to D1-like dopamine sites in rat striatum: possible role in dopamine-mediated inositol phosphate formation | Q28574449 | ||
PDZ domain proteins of synapses | Q29616399 | ||
RGSZ1 interacts with protein kinase C interacting protein PKCI-1 and modulates mu opioid receptor signaling | Q33264634 | ||
Ca2+-calmodulin and protein kinase Cs: a hypothetical synthesis of their conflicting convergences on shared substrate domains | Q33544237 | ||
Modulation of NMDA and AMPA-mediated synaptic transmission by CB1 receptors in frontal cortical pyramidal cells | Q33923685 | ||
Glutaminergic hypothesis of schizophrenia: clinical research studies with ketamine | Q33941785 | ||
Synaptic versus extrasynaptic NMDA receptor signalling: implications for neurodegenerative disorders | Q34138025 | ||
Peripheral profiling analysis for bipolar disorder reveals markers associated with reduced cell survival. | Q34156394 | ||
Therapeutic implications for striatal-enriched protein tyrosine phosphatase (STEP) in neuropsychiatric disorders. | Q34233293 | ||
Differential tyrosine phosphorylation of N-methyl-D-aspartate receptor subunits | Q34294351 | ||
Properties of synaptically evoked astrocyte calcium signal reveal synaptic information processing by astrocytes. | Q34399862 | ||
Cannabinoids produce neuroprotection by reducing intracellular calcium release from ryanodine-sensitive stores. | Q34420730 | ||
A peripheral mononeuropathy in rat that produces disorders of pain sensation like those seen in man. | Q34554719 | ||
Hits, Fhits and Nits: beyond enzymatic function. | Q34586553 | ||
Cell pathology in mood disorders | Q34968512 | ||
Rethinking the excitotoxic ionic milieu: the emerging role of Zn(2+) in ischemic neuronal injury. | Q35699474 | ||
Src kinases: a hub for NMDA receptor regulation | Q35701114 | ||
Regulation of N-methyl-D-aspartic acid (NMDA) receptors by metabotropic glutamate receptor 7 | Q35879968 | ||
Prevention and repair of circulatory shock and cerebral ischemia/injury by various agents in experimental heatstroke | Q36683402 | ||
Cannabinoid receptor stimulation is anti-inflammatory and improves memory in old rats | Q36980744 | ||
The role of glutamate in mood disorders: results from the ketamine in major depression study and the presumed cellular mechanism underlying its antidepressant effects | Q37067679 | ||
Beta-catenin takes a HIT. | Q37205630 | ||
Signaling pathways from cannabinoid receptor-1 activation to inhibition of N-methyl-D-aspartic acid mediated calcium influx and neurotoxicity in dorsal root ganglion neurons | Q37444391 | ||
Glutamate receptor phosphorylation and trafficking in pain plasticity in spinal cord dorsal horn | Q37772543 | ||
Direct association of Mu-opioid and NMDA glutamate receptors supports their cross-regulation: molecular implications for opioid tolerance. | Q38037679 | ||
Neuroprotection against hypoxia/ischemia: δ-opioid receptor-mediated cellular/molecular events. | Q38046756 | ||
The plasticity of the association between mu-opioid receptor and glutamate ionotropic receptor N in opioid analgesic tolerance and neuropathic pain. | Q38090227 | ||
Nitric oxide and zinc-mediated protein assemblies involved in mu opioid receptor signaling. | Q38105951 | ||
Developmental regulation of 5-HT2 and 5-HT1c mRNA and receptor levels | Q38337006 | ||
Ketamine produces effective and long-term pain relief in patients with Complex Regional Pain Syndrome Type 1. | Q39300898 | ||
The mu-opioid receptor and the NMDA receptor associate in PAG neurons: implications in pain control. | Q39904357 | ||
Direct interaction enables cross-talk between ionotropic and group I metabotropic glutamate receptors | Q40027235 | ||
Tyrosine kinase potentiates NMDA receptor currents by reducing tonic zinc inhibition | Q40962336 | ||
Retinoic acid regulates the developmental expression of dopamine D2 receptor in rat striatal primary cultures. | Q41012314 | ||
Heatstroke-induced cerebral ischemia and neuronal damage. Involvement of cytokines and monoamines | Q41430359 | ||
Adenylyl cyclase activation modulates activity-dependent changes in synaptic strength and Ca2+/calmodulin-dependent kinase II autophosphorylation. | Q41615359 | ||
NO-released zinc supports the simultaneous binding of Raf-1 and PKCγ cysteine-rich domains to HINT1 protein at the mu-opioid receptor. | Q41879563 | ||
Gz mediates the long-lasting desensitization of brain CB1 receptors and is essential for cross-tolerance with morphine | Q41958365 | ||
Displacement of alpha-actinin from the NMDA receptor NR1 C0 domain By Ca2+/calmodulin promotes CaMKII binding | Q42129724 | ||
Down-regulation of 3H-lofentanil binding to opiate receptors in different cultured neuronal cells | Q42190023 | ||
Role of mPKCI, a novel mu-opioid receptor interactive protein, in receptor desensitization, phosphorylation, and morphine-induced analgesia | Q42469460 | ||
Properties and distribution of the protein inhibitor (Mr 17,000) of protein kinase C. | Q42855610 | ||
Cannabinoid receptors couple to NMDA receptors to reduce the production of NO and the mobilization of zinc induced by glutamate. | Q42872711 | ||
Agonists determine the pattern of G-protein activation in mu-opioid receptor-mediated supraspinal analgesia. | Q43557580 | ||
Stimulated D(1) dopamine receptors couple to multiple Galpha proteins in different brain regions | Q43735189 | ||
Pre- and postsynaptic localizations of the CB1 cannabinoid receptor in the dorsal horn of the rat spinal cord. | Q43948450 | ||
Glycosylated phosducin-like protein long regulates opioid receptor function in mouse brain | Q43996585 | ||
Tyrosine phosphorylation of the NR2B subunit of the NMDA receptor in the spinal cord during the development and maintenance of inflammatory hyperalgesia. | Q44067041 | ||
Ultrastructural localization of the CB1 cannabinoid receptor in mu-opioid receptor patches of the rat Caudate putamen nucleus. | Q44334367 | ||
Sustained potentiation of NMDA receptor-mediated glutamate responses through activation of protein kinase C by a μ opioid | Q44335232 | ||
NMDAR-nNOS generated zinc recruits PKCgamma to the HINT1-RGS17 complex bound to the C terminus of Mu-opioid receptors. | Q44339601 | ||
The histidine triad nucleotide-binding protein 1 supports mu-opioid receptor-glutamate NMDA receptor cross-regulation | Q44348688 | ||
Mu-opioid receptor blockade protects against circulatory shock and cerebral ischemia during heatstroke | Q44351115 | ||
Pre- and postsynaptic distribution of cannabinoid and mu opioid receptors in rat spinal cord | Q44351566 | ||
Locus-specific rescue of GluRepsilon1 NMDA receptors in mutant mice identifies the brain regions important for morphine tolerance and dependence. | Q44524204 | ||
Regulation of dopamine D1 receptor function by physical interaction with the NMDA receptors. | Q44755344 | ||
Involvement of brain-derived neurotrophic factor in cannabinoid receptor-dependent protection against excitotoxicity | Q44840035 | ||
Acute behavioral effects of nicotine in male and female HINT1 knockout mice | Q44977420 | ||
Glutamate released from glial cells synchronizes neuronal activity in the hippocampus. | Q45007585 | ||
Neuronal synchrony mediated by astrocytic glutamate through activation of extrasynaptic NMDA receptors. | Q45038421 | ||
Enhanced activation of Akt and extracellular-regulated kinase pathways by simultaneous occupancy of Gq-coupled 5-HT2A receptors and Gs-coupled 5-HT7A receptors in PC12 cells | Q45192487 | ||
Zinc selectively blocks the action of N-methyl-D-aspartate on cortical neurons | Q45194545 | ||
Regulation of NMDA channel function by endogenous Ca(2+)-dependent phosphatase | Q46364713 | ||
Involvement of cannabinoid receptors in the regulation of neurotransmitter release in the rodent striatum: a combined immunochemical and pharmacological analysis. | Q46384445 | ||
Inhibition of protein phosphatase 2B upregulates serine phosphorylation of N-methyl-D-aspartate receptor NR1 subunits in striatal neurons in vivo | Q46487506 | ||
Endocannabinoids mediate neuron-astrocyte communication | Q46682045 | ||
Hint1 is a haplo-insufficient tumor suppressor in mice | Q46722746 | ||
Ipsapirone and ketanserin protects against circulatory shock, intracranial hypertension, and cerebral ischemia during heatstroke | Q46736236 | ||
Molecular mechanisms of cannabinoid protection from neuronal excitotoxicity | Q46813276 | ||
mPins modulates PSD-95 and SAP102 trafficking and influences NMDA receptor surface expression | Q46813527 | ||
Phosphorylation-dependent regulation of N-methyl-D-aspartate receptors by calmodulin | Q48637162 | ||
GPCRs promote the release of zinc ions mediated by nNOS/NO and the redox transducer RGSZ2 protein. | Q48685376 | ||
Characterization of protein kinase A and protein kinase C phosphorylation of the N-methyl-D-aspartate receptor NR1 subunit using phosphorylation site-specific antibodies | Q48797328 | ||
G-protein-coupled receptors act via protein kinase C and Src to regulate NMDA receptors | Q48920822 | ||
Separating dual effects of zinc at recombinant N-methyl-D-aspartate receptors. | Q50760360 | ||
Inhibition of Morphine Tolerance and Dependence by the NMDA Receptor Antagonist MK-801 | Q52052445 | ||
A light and electron microscopic study of the CB1 cannabinoid receptor in the primate spinal cord | Q60155184 | ||
Electrophysiologic Analysis of Preemptive Effects of Spinal Opioids on N-methyl-D-aspartate Receptor--mediated Events | Q60679694 | ||
P407 | language of work or name | English | Q1860 |
P921 | main subject | cannabinoid receptor | Q421237 |
cannabinoids | Q422936 | ||
CNR2 | Q17907844 | ||
P304 | page(s) | 42 | |
P577 | publication date | 2013-10-05 | |
P1433 | published in | Molecular Brain | Q6895938 |
P1476 | title | HINT1 protein cooperates with cannabinoid 1 receptor to negatively regulate glutamate NMDA receptor activity | |
P478 | volume | 6 |
Q55252194 | Cannabinoid Receptors and the Endocannabinoid System: Signaling and Function in the Central Nervous System. |
Q48820966 | Cannabinoid-glutamate interactions in the regulation of food intake in neonatal layer- type chicks: role of glutamate NMDA and AMPA receptors |
Q38819251 | Cannabinoids: Glutamatergic Transmission and Kynurenines |
Q42317501 | Endocannabinoid control of glutamate NMDA receptors: the therapeutic potential and consequences of dysfunction |
Q55340475 | Fenfluramine diminishes NMDA receptor-mediated seizures via its mixed activity at serotonin 5HT2A and type 1 sigma receptors. |
Q47204896 | HINT1 in Neuropsychiatric Diseases: A Potential Neuroplastic Mediator |
Q36948351 | Hint1 gene deficiency enhances the supraspinal nociceptive sensitivity in mice. |
Q37668134 | Increased PKC activity and altered GSK3β/NMDAR function drive behavior cycling in HINT1-deficient mice: bipolarity or opposing forces |
Q41572995 | Interactions between the Kynurenine and the Endocannabinoid System with Special Emphasis on Migraine |
Q47284001 | Schizophrenia and depression, two poles of endocannabinoid system deregulation |
Q42701910 | Social isolation induces schizophrenia-like behavior potentially associated with HINT1, NMDA receptor 1, and dopamine receptor 2. |
Q38262682 | The ON:OFF switch, σ1R-HINT1 protein, controls GPCR-NMDA receptor cross-regulation: implications in neurological disorders |
Q47900550 | The Role of HINT1 in Methamphetamine-Induced Conditioned Place Preference |
Q38639528 | The Sigma-1 Receptor Antagonist, S1RA, Reduces Stroke Damage, Ameliorates Post-Stroke Neurological Deficits and Suppresses the Overexpression of MMP-9. |
Q51750311 | The calcium-sensitive Sigma-1 receptor prevents cannabinoids from provoking glutamate NMDA receptor hypofunction: implications in antinociception and psychotic diseases. |
Q34659000 | The cannabinoid receptor 1 associates with NMDA receptors to produce glutamatergic hypofunction: implications in psychosis and schizophrenia. |
Q43195386 | The σ1 receptor engages the redox-regulated HINT1 protein to bring opioid analgesia under NMDA receptor negative control |
Q48608696 | Why sigma-1 receptor dysfunction might confer vulnerability to cannabis-induced psychosis |
Search more.